[go: up one dir, main page]

BG108390A - Medicamentous form and method for the production thereof - Google Patents

Medicamentous form and method for the production thereof

Info

Publication number
BG108390A
BG108390A BG108390A BG10839003A BG108390A BG 108390 A BG108390 A BG 108390A BG 108390 A BG108390 A BG 108390A BG 10839003 A BG10839003 A BG 10839003A BG 108390 A BG108390 A BG 108390A
Authority
BG
Bulgaria
Prior art keywords
production
medicamentous
triacetoneamine
sulphonate
toluene
Prior art date
Application number
BG108390A
Other languages
Bulgarian (bg)
Other versions
BG65676B1 (en
Inventor
Ангел ТИМЧЕВ
Виолета ПАВЛОВА
Радка ГРОЗДЕВА
Веселин ДАСКАЛОВ
Влайко ТОНЕВ
Бисер КЪТОВСКИ
Стилиан СИМЕОНОВ
Original Assignee
"Софарма" Ад
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Софарма" Ад filed Critical "Софарма" Ад
Priority to BG108390A priority Critical patent/BG65676B1/en
Publication of BG108390A publication Critical patent/BG108390A/en
Publication of BG65676B1 publication Critical patent/BG65676B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicamentous form of a combined preparation for human medicine in the form of a film tablet containing metamysol sodium, triacetoneamine-4-toluene-sulphonate, auxiliary substances, such as wheat starch, talcum, magnesium stearate, as well as copovidon from 10 to 50 mg. The medicamentous form is stable, the tablet has reduced mass and improved degree of dissolution of triacetoneamine-4-toluene-sulphonate. The invention also relates to a method for the production thereof.
BG108390A 2003-11-27 2003-11-27 Drug formulation and method of obtaining it BG65676B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG108390A BG65676B1 (en) 2003-11-27 2003-11-27 Drug formulation and method of obtaining it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG108390A BG65676B1 (en) 2003-11-27 2003-11-27 Drug formulation and method of obtaining it

Publications (2)

Publication Number Publication Date
BG108390A true BG108390A (en) 2005-05-31
BG65676B1 BG65676B1 (en) 2009-06-30

Family

ID=34624306

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108390A BG65676B1 (en) 2003-11-27 2003-11-27 Drug formulation and method of obtaining it

Country Status (1)

Country Link
BG (1) BG65676B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG63147B1 (en) * 1997-05-12 2001-05-31 Виолета АНДОНОВА Medicamentous form

Also Published As

Publication number Publication date
BG65676B1 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
MXPA04005105A (en) Directly compressible formulations of azithromycin.
MY137768A (en) Rapidly disintegrating methylcellulose tablets
HUP0203257A2 (en) Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them
MXPA01004547A (en) Oral administration of adenosine analogs.
MY128046A (en) Rapidly disintegrating methylcellulose tablets
SE0001899D0 (en) New compounds
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
UA41346C2 (en) Pharmaceutical composition containing fluoxetin or its salt, tablet based on composition thereof, method for manufacturing dispersed tablets
BG105173A (en) Novel salt form of pantoprazole
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
TW200700062A (en) Pharmaceutical compositions
DE69815856D1 (en) CEFADROXILMONOHYDRATE TABLET FORMULATION
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
MXPA04003346A (en) Flashmelt oral dosage formulation.
EA201001108A1 (en) TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA03011317A (en) Swallow tablet comprising paracetamol.
HUP0001780A2 (en) Stabilized tibolone compositions and process for their preparation
BR0013106A (en) Floating pharmaceutical composition, tablet, and tablet preparation process.
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
DE50313132D1 (en) PHARMACEUTICAL PREPARATIONS OF INHIBITORS OF AMINO-PEPIDIDASE N, WHERE APPROPRIATE, IN COMBINATION WITH DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE THERAPY AND PREVENTION OF DERMATOLOGICAL ILLNESSES WITH SEBOZYTE HYPERPROLIFERATION AND CHANGED DIFFERENTIATION STATES
GR1004193B (en) Pharmaceutical composition containing citalopram
AU2003275875A1 (en) Edible dissolving gelatin strips
MXPA06010146A (en) Bioavailable solid dosage forms of metaxalone.